Deciphering Multidrug-Resistant Pseudomonas aeruginosa: Mechanistic Insights and Environmental Risks

Yang Pei1,2,3, Péter Hamar4, De-Sheng Pei1

  • 1School of Public Health, Chongqing Medical University, Chongqing 400016, China.

Toxics
|April 25, 2025
PubMed

Insights

Multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) poses clinical and environmental threats. This review explores resistance mechanisms, detection, and novel therapies, emphasizing integrated solutions for antimicrobial resistance.

Area of Science:

  • Microbiology
  • Genetics
  • Environmental Science

Background:

  • Multidrug-resistant (MDR) *Pseudomonas aeruginosa* (*P. aeruginosa*) is a growing clinical and environmental concern.
  • Understanding the mechanisms of MDR development is crucial for effective treatment and control.

Purpose of the Study:

  • To review the mechanisms of MDR development in *P. aeruginosa*.
  • To evaluate current and emerging detection and therapeutic strategies.
  • To highlight the environmental risks and adaptability of MDR *P. aeruginosa*.

Main Methods:

  • Literature review of genetic mutations, horizontal gene transfer (HGT), and virulence factors.
  • Evaluation of traditional and molecular diagnostic techniques.
  • Analysis of existing and novel therapeutic interventions, including gene editing technologies.

Main Results:

  • MDR development involves genetic mutations, HGT, and gene-virulence factor interactions.
  • Rapid and accurate diagnostics are essential.
  • Innovative therapies like RNA interference and CRISPR-Cas9 show promise.
  • MDR *P. aeruginosa* exhibits significant environmental distribution and adaptability.

Conclusions:

  • An integrated approach combining genomics, clinical practice, and environmental monitoring is necessary.
  • Continued research and development are vital to combat antimicrobial resistance.
  • Preserving antibiotic efficacy requires multifaceted strategies against MDR *P. aeruginosa*.